Trial Profile
A safety and efficacy study of intravenous peramivir in children with severe influenza infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2015 New trial record